Inventor
BEMBENEK SCOTT D
US11 patents
⚠️ This page may combine multiple inventors who share the name “BEMBENEK SCOTT D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
10 patentsUS10717745B2Jul 21, 2020
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV5 citations82
US8367719B2Feb 5, 2013
Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
JANSSEN PHARMACEUTICA NV5 citations82
US12065446B2Aug 20, 2024
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV1 citations72
US11319329B2May 3, 2022
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV1 citations72
US7935725B2May 3, 2011
Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
JANSSEN PHARMACEUTICA NV6 citations72
US10934310B2Mar 2, 2021
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV4 citations71
US8344008B2Jan 1, 2013
Aryl-substituted bridged or fused diamines as modulators of leukotriene A ydrolase
JANSSEN PHARMACEUTICA NV5 citations69
US10822348B2Nov 3, 2020
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV0 citations50
US10800792B2Oct 13, 2020
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV0 citations50
US10689396B2Jun 23, 2020
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV0 citations50